Data on the pharmacological activity of trecrezan -a new domestic adaptogen and immunomodulator -are presented. A brief history of the drug creation, the chemical structure, and the immunostimulant and antistressor effects are considered. Trecrezan is recommended for complex therapy of patients with myocardial infarction, hepatitis, radiation-induced diseases, and pancreonecrosis. The administration of trecrezan stimulates proliferative and reparative processes, thus offering good prospects in surgical practice for the accelerated healing of purulent-necrotic disorders and postoperation wounds.